(Q53607721)

16 May 2018

title

Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis. (English)

1 reference

16 May 2018

1 reference

4

1 reference

16 May 2018

author name string

Minutolo R

1

1 reference

16 May 2018

Balletta MM

2

1 reference

16 May 2018

Catapano F

3

1 reference

16 May 2018

Tirino G

5

1 reference

16 May 2018

Zamboli P

6

1 reference

16 May 2018

Fuiano G

7

1 reference

16 May 2018

Russo D

8

1 reference

16 May 2018

Marotta P

9

1 reference

16 May 2018

Iodice C

10

1 reference

16 May 2018

Conte G

11

1 reference

16 May 2018

De Nicola L

12

1 reference

16 May 2018

language of work or name

English

0 references

publication date

2 August 2006

1 reference

16 May 2018

published in

Kidney International

1 reference

16 May 2018

volume

70

1 reference

16 May 2018

issue

6

1 reference

16 May 2018

page(s)

1170-1176

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.ki.5001732

exact match

0 references

cites work

Chronic kidney disease: the global challenge

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Renoprotective therapy: titration against urinary protein excretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Proteinuria and the risk of developing end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Efficacy and safety of benazepril for advanced chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Dual renin-angiotensin system blockade at optimal doses for proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Nephrotic Proteinuria Without Hypoalbuminemia: Clinical Characteristics and Response to Angiotensin-Converting Enzyme Inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Salt intake and progression of chronic kidney disease: an overlooked modifiable exposure? A commentary.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Tissue-specific expression of renin-angiotensin system components in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Angiotensin II receptor-mediated proliferation of cultured human fetal mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Regression of IgA nephropathy: a repeat biopsy study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Progression versus regression of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

1 reference

7 January 2021

Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

The Banff 97 working classification of renal allograft pathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Morphological studies of baseline needle biopsies from living donor kidneys: light microscopic, immunohistochemical and ultrastructural findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001732

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001732

1 reference

16 May 2018

Dimensions Publication ID

1041360873

0 references

1 reference

16 May 2018